This page shows the latest Livazo news and features for those working in and with pharma, biotech and healthcare.
The Italian firm has already launched its own oral treatment for disorders of lipoprotein metabolism, Livazo (pitavastatin), on the Swiss market, having been approved for use in adults by the European
More from news
Approximately 1 fully matching, plus 0 partially matching documents found.
Out of the 10 products assessed last year, four have obtained poor innovation scores: Esbriet (pirfenidone), Livazo (pitavastatin), Yellox (bromfenac) and Trajenta (linagliptin) and a majority of manufacturers have struggled – sometimes
More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.
No results were found
Oxford PharmaGenesis is an independently owned HealthScience communications consultancy, providing services to the healthcare industry, professional societies and patient groups....